Institutional investors purchased a net $4.8 million shares of THRX during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 88.10% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IRIDIAN ASSET MANAGEMENT LLC Bought 3.2 Million shares of Theravance Inc
STATE STREET GLOBAL ADVISORS IRE... Bought 615.00 shares of Theravance Inc
ATHENAINVEST ADVISORS LLC Sold 25.2 Thousand shares of Theravance Inc